drugset / Trial / NCT04880928

Comparison Mydriasis by Mydrane With Topical Drop Application

NCT04880928

Phase 4 Completed 42 enrolled Medical University of Graz
RandomizedCrossoverSingle-blindTreatment

Summary

The primary aim of the study is to compare the effectiveness of the intracameral application of Mydrane® (standardized combination of Tropicamide 0.02%, Phenylephrine 0.31% and Lidocaine 1%) with the preoperative topical application (Tropicamide 0.5% and Phenylephrine 10%). To evaluate the steadiness of the dilating effect on the pupil, the ratio of eyes without necessity for further pupil dilating procedures to perform the capsulorhexis is assessed.

Timeline

Start
2020-08-12
Primary completion
2021-09-23
Completion
2021-09-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 10 mg/ml Other
Comparator Phenylephrine Small molecule 3.1 mg/ml Other
Comparator Phenylephrine Small molecule 10 % Other
Comparator tropicamide Small molecule 0.2 mg/ml Other
Comparator tropicamide Small molecule 0.5 % Other

Indications